Comera Life Sciences Holdings, Inc.
CMRA
$0.0001
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -9.01M | -9.93M | -17.61M | -18.00M | -17.07M |
| Total Depreciation and Amortization | 99.90K | 100.70K | 97.50K | 94.00K | 94.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 838.90K | 858.10K | 5.82M | 5.59M | 5.53M |
| Change in Net Operating Assets | 1.41M | 1.84M | 2.88M | 2.55M | 1.91M |
| Cash from Operations | -6.66M | -7.14M | -8.81M | -9.77M | -9.53M |
| Capital Expenditure | -94.10K | -119.30K | -117.10K | -28.70K | -159.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -94.10K | -119.30K | -117.10K | -28.70K | -159.20K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -1.17M | -1.58M | -1.52M | -1.06M | -604.90K |
| Issuance of Common Stock | 5.97M | 2.87M | 6.40M | 4.80M | 4.72M |
| Repurchase of Common Stock | -200.00 | -200.00 | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -453.00K | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.51M | 1.51M | 1.71M | 1.51M | 0.00 |
| Cash from Financing | 5.85M | 2.79M | 6.60M | 5.24M | 4.11M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -901.50K | -4.46M | -2.32M | -4.56M | -5.57M |